Skip to Post Results

Article Results:

[Feb 01, 2016] Biogen, by Mark Robertson
The biotech industry has been hammered over the last several months. Among the carnage, BIIB.

[Jul 01, 2018] Tin Cup Demonstration Portfolio (July 2018), by Mark Robertson
Yet another strong month for Tin Cup, beating the Wilshire 5000 in 10-of-the-last 11 months. We accumulate CVS Health (CVS) and celebrate the near all-time high value of total assets while challenging Biogen (BIIB) after its recent surge.

[Dec 01, 2018] Tin Cup Demonstration Portfolio (December 2018), by Mark Robertson
Tin Cup had a much better month. The progress restored during November was a welcome relief to the gruesome angst of an October to forget. Total assets soared at month-end to make the last (12) months -- as challenging as they’ve been -- a little more palatable. We note that the year-over-year gain is still $79,932 during a most difficult general stock market.

[Jan 01, 2016] Sweet Sixteen, by Mark Robertson
The Long & Short Of It

[Mar 01, 2016] Tin Cup Model Portfolio , by Mark Robertson
Add Polaris, Sell Coach (COH), Buy CERN & BIIB

[Jul 01, 2005] Nasdaq-100 (QQQQ), by Mark Robertson
QQQQ is designed to follow the NASDAQ-100 index composed of 100 of the fastest growing technology and non-financial services companies listed on the NASDAQ Stock Market..

[Dec 10, 2016] iShares Morningstar Large Growth (JKE), by Mark Robertson
This month, we remind again that small-cap does not necessarily mean small company.

[Mar 01, 2016] Sweet 16: Round Table Hunting I, by Mark Robertson
It was the worst of times ... and then it was the best of times? The first quarter of 2016 was the most dismal in history for a few weeks.

[Feb 01, 2018] Tin Cup Demonstration Portfolio (February 2018), by Mark Robertson
Hello $2,000,000! If you squint carefully at that long term chart of total assets, we see that January 2018 was one of the biggest bumps to the upside for a single month, ever.

[Aug 01, 2018] Tin Cup Demonstration Portfolio (August 2018), by Mark Robertson
Tin Cup approaches all-time highs again. We accumulate CVS Health (CVS) and place Qualcomm (QCOM) squarely on the challenge hot seat.

Skip to Article Results

Forum Post Results:

Biogen (BIIB) · by Mark Robertson · 06/29/2016 10:10 AM · Stocks
Cy Lynch accumulated Biogen (BIIB) during the June session of the Round Table.

Biogen (BIIB) · by Mark Robertson · 07/26/2017 09:51 AM · Stocks
Goldman Sachs upgrades Biogen (BIIB) from Neutral to Buy.

Biogen (BIIB) · by Matt Spielman · 06/07/2021 07:49 PM · Stocks
In a vindication of Hugh’s interest, Biogen ended the day up 38%, and was as high as $458 a share intraday on news of the FDA approval of...

Biogen (BIIB) · by Matt Spielman · 11/04/2020 04:56 PM · Stocks
An article in The Wall Street Journal clarifies that the positive review is from one FDA staffer, in documents released before a meeting of the...

Biogen (BIIB) · by Matt Spielman · 11/08/2020 01:05 PM · Stocks
Biogen’s stock trading was halted all day Friday, as the FDA review panel convened. Interestingly, the panel voted against approval. citing the...

Biogen (BIIB) · by Matt Spielman · 11/09/2020 10:21 AM · Stocks
On a positive day for so many, Biogen is down more than 30%, as revised analyst ratings came out over the weekend.

Biogen (BIIB) · by Marie Frank · 06/07/2021 09:05 PM · Stocks
I bailed years ago after listening to a doctor explain how they were manipulating the efficacy of certain drugs. Given the challenge, the...

Biogen (BIIB) · by Matt Spielman · 06/08/2021 08:37 AM · Stocks
Marie, I don’t think It’s a surprise the daily RSI is that high on a day up 38%, on 17x daily volume. I am sure every short tried to cover...

Biogen (BIIB) · by Matt Spielman · 06/11/2021 08:17 AM · Stocks
A third member of the 11-member FDA advisory panel on nervous system therapies has resigned over the FDA’a approval of Aduhelm. The committee had...

Biogen (BIIB) · by Mark Robertson · 06/12/2021 09:07 AM · Stocks
Strikes me as a little bizarre … perhaps we’ll get some chiming from Hugh … Memorable Approval (Source: Seeking Alpha) The FDA cleared the first...

Biogen (BIIB) · by Matt Spielman · 12/30/2021 09:40 AM · Stocks
Even a buyout is a rollercoaster for Biogen. It was up 10% yesterday on news of a buyout by Samsung biologics,. The deal, reportedly part of a...

Biogen (BIIB) · by Matt Spielman · 01/28/2022 09:17 AM · Stocks
Well, the rumor was explained today, as Samsung Biologics disclosed it is buying Biogen’s share of their biosimilars joint venture. The deal brings...

Biogen (BIIB) · by Matt Spielman · 01/12/2022 10:07 AM · Stocks
Biogen is down 9% today, after Medicare’s initial declaration that Aduhelm will be covered, but only for those in clinical trials of the drug....

Biogen (BIIB) · by Marie Frank · 07/23/2022 12:27 PM · Stocks
After failed Alzheimer’s launch, Biogen writes off the remaining value of its Aduhelm inventory Biogen is trying to escape the dark Aduhelm cloud...

Biogen (BIIB) · by Mark Robertson · 06/09/2023 04:50 PM · Stocks
FDA panel unanimously endorses Leqembi for full approval An FDA advisory panel voted 6 to 0 recommending that Eisai and Biogen’s Alzheimer’s drug...

Sold Biogen (BIIB) · by Anne Manning · 04/13/2020 01:02 PM · Decisions Manifest
Forgot to say that the quality rating of Biogen has dropped a good bit recently. I looked and the low price was $282.25 in March, so it has had a...

Sold Biogen (BIIB) · by Anne Manning · 04/13/2020 12:58 PM · Decisions Manifest
Decided to look at some more of my stocks that I have made profits on. Biogen was at a low of $219.75 last August to today’s price of $322.72....

Sold Biogen (BIIB) · by Leonard Douglass · 04/13/2020 06:16 PM · Decisions Manifest
In today’s New York Times https://www.nytimes.com/2020/04/12/us/coronavirus-biogen-boston-superspreader.html Definitely NOT good PR for the...

Solomon Select: Biogen (BIIB) · by Mark Robertson · 02/17/2016 11:21 AM · Stocks
Solomon Select (February 2016) Biogen (BIIB) The biotech industry has been hammered over the last several months.It figures that the companies with...

Biogen (BIIB): Alzheimer Progress? · by Mark Robertson · 09/28/2022 11:10 AM · Stocks
Alzheimer’s drug shows promise. Lecanemab, an Alzheimer’s drug from Eisai and Biogen (BIIB), slowed cognitive decline in patients with early...

Biogen (BIIB): Alzheimer Progress? · by Mark Robertson · 09/29/2022 09:23 AM · Stocks
Biogen, a major biotech company, saw its stock price explode upward by over 35% in mid-morning trading. The quotation soared after a Phase III...

Biogen (BIIB) · by Matt Spielman · 11/04/2020 12:48 PM · Stocks
Biogen surged nearly 50% today on an FDA panel’s finding supporting approval for its Alzheimer’s drug aducanumab. Bonus points to Hugh for slipping...

Bought BIIB · by Anne Manning · 03/30/2016 02:36 PM · Decisions Manifest
Had been looking at Biogen for the last couple of months. Thanks to Cy’s Round Table presentation last night, I decided to purchase.

Crossing Wall Street Weekly Update (10/28/2016) · by Mark Robertson · 10/28/2016 08:58 AM · Stocks
This week’s update from Eddy Elfenbein at www.crossingwallstreet.com includes a number of community favorites: AFLAC (AFL) Bard CR (BCR) Biogen...

Round Table (January 2016) · by Mark Robertson · 01/27/2016 07:26 AM · Stocks
The audience selected Biogen IDEC (BIIB) — in harmony with Cy and Ken, and the numerous appearances at the top of the various screens and lists of...

CWS Update: ADS BIIB MSFT SNA SYK WFC · by Mark Robertson · 07/22/2016 12:44 PM · Stocks
http://www.crossingwallstreet.com/archives/2016/07/cws-market-review-july-22-2016.html

Sold BIIB, GILD Bought CAKE, DIS, EBS, HLI · by Matt Spielman · 03/08/2022 10:43 AM · Decisions Manifest
Tired of waiting on those two, with so many at 52-week lows. Gilead’s announcement of phase 3 trials on breast cancer were reviewed as “mixed,”...

Round Table (January 2016) · by Mark Robertson · 01/27/2016 07:58 AM · Stocks
Adding Biogen IDEC (BIIB) to the tracking portfolio with $3000 for an initial position … $1000 in Hibbett Sporting Goods (HIBB) and accumulating...

Round Table (March 2016) · by Mark Robertson · 03/29/2016 10:18 AM · Stocks
Round Table (March 2016) Stocks Featured Biogen (BIIB) BP plc (BP) Celgene (CELG) Neogen* (NEOG) The audience selected Neogen (NEOG). The...

Teva Pharma (TEVA) · by Mark Robertson · 03/27/2013 04:35 PM · Stocks
Teva Pharma (TEVA) came up for discussion during the March Round Table and we committed to a closer look at TEVA and the generic drug industry for...

Groundhog Challenge XI (2017): Rules of Engagement · by Paul Witt · 02/02/2017 04:15 AM · Groundhog Challenge
2017 picks FIVE BIIB HCSG PII TROW

Round Table (June 2016) · by Mark Robertson · 06/28/2016 12:34 PM · Stocks
Stocks Likely To Be Discussed Bank of America (BAC) Biogen (BIIB) Mesa Labs (MLAB) Robert Half (RHI) Registration The session started at 8:30 PM...

This Week at MANIFEST (4/1/2016) · by Mark Robertson · 03/28/2016 02:52 PM · General Discussion
March Round Table March 29, 2016 at 8:30 PM ET ONLINE Stocks Featured: Biogen (BIIB), BP (BP), Celgene (CELG), Neogen (NEOG) The Round Table...

Groundhog Challenge Scoreboard (2016) · by Mark Robertson · 02/09/2017 08:55 AM · Groundhog Challenge
Actually both tickers are right BIVVV was the transitional ticker for BIVV. It’ll be added to our database as BIVV. The BIVVV position in any...

Fave Five (2/12/2016) · by Mark Robertson · 02/12/2016 10:18 AM · Stocks
Fave Five (2/12/2016) Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according...

Fave Five (3/11/2016) · by Mark Robertson · 03/11/2016 10:05 AM · Stocks
Fave Five (3/11/2016) Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according...

Fave Five (3/18/2016) · by Mark Robertson · 03/19/2016 10:26 AM · Stocks
Fave Five (3/18/2016) Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according...

Fave Five (4/1/2016) · by Mark Robertson · 04/01/2016 08:54 AM · Stocks
Fave Five (4/1/2016) Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according...

2016 Groundhog challenge · by Charles Brunell · 02/01/2016 09:43 PM · Groundhog Challenge
My picks CTSH BIIB FB ISRG TAL ROST

Round Table (January 2016) · by Mark Robertson · 01/26/2016 11:39 AM · Stocks
Round Table (January 2016) What: Round Table Discussion of Favorite Stock Study Ideas When: Tuesday, January 26 at 8:30 PM ET Where: Online....

Expected Returns, February 2016 · by Kurt Kowitz · 03/04/2016 08:57 AM · Announcements & Events
Expected Returns, February 2016 A group of investors heeding the lessons of Graham, Babson and Nicholson has at least one leg up on the crowd and a...

This Week at MANIFEST (7/8/2016) · by Mark Robertson · 07/05/2016 08:55 AM · General Discussion
Companies of Interest: Value Line (7/8/2016) The average Value Line low total return forecast for the companies in this week’s update batch is 6.8%...

3 Great Aggressive Funds (Morningstar) · by Mark Robertson · 08/25/2023 07:31 AM · Funds & Retirement Plans
3 Great Aggressive Growth Funds (Russ Kinnel, Morningstar) Russ is barking at our tree of Little Rascals. As a source of ideas, they’re all good...

BIVV · by Jim Erickson · 03/27/2017 05:31 PM · Support & Suggestions
Please add BIVV (spin off from Biogen) to covered Thanks